Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-785 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
filingDate |
2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eefe737a36f72df8699d75573d64efe3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dbb9fedee24085034ced4f661b4a458 |
publicationDate |
2014-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014079898-A1 |
titleOfInvention |
Reconstituted pulmonary surfactants |
abstract |
The present invention is directed to a reconstituted surfactant comprising a phospholipid mixture, and a combination of particular analogues of the native surfactant protein SP-C with analogues of the native surfactant protein SP-B. The invention is also directed to pharmaceutical compositions and kits thereof and to its use for the treatment or prophylaxis of RDS and other respiratory disorders. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11213573-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101721309-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021151853-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101784651-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160103211-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018096057-A1 |
priorityDate |
2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |